Am J Ther. 2012 Sep 24. [Epub ahead of print]
Food and Drug Administration Approval of Cetuximab and a New KRAS Genetic Test for Metastatic Colorectal Cancer: Major Advance but Just the Tip of the Biomarker Iceberg.
SourceDepartment of Hematology, Oncology and Transplantation, Quintiles, Inc, Rockville, MD.
- [PubMed - as supplied by publisher]